Rheumatic fever prevention program: long-term evolution and outcomes

被引:12
|
作者
Coelho Mota, Cleonice Carvalho [1 ]
Alves Meira, Zilda Maria [1 ]
Graciano, Rosangela Nicoli [1 ]
Graciano, Fernando Felipe [1 ]
Rocha Araujo, Fatima Derlene [2 ]
机构
[1] Univ Fed Minas Gerais, Hosp Clin, Dept Pediat, Belo Horizonte, MG, Brazil
[2] Univ Fed Minas Gerais, Hosp Clin, Belo Horizonte, MG, Brazil
来源
FRONTIERS IN PEDIATRICS | 2014年 / 2卷
关键词
rheumatic fever; rheumatic heart disease; secondary prophylaxis; recurrences; valvar dysfunction;
D O I
10.3389/fped.2014.00141
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
This investigation aims to analyze the profile of long-term evolution of rheumatic fever in children and adolescents and outcomes after the control of recurrences. The cohort involved 702 patients followed from 1.3 to 16.9 years covering the two periods, before and after the implementation of a prevention program. Besides the establishment of the Reference Center in the State of Minas Gerais and the implementation of strategies to promote the compliance to prophylaxis, a project for education of health professionals was carried out in 23 cities. In addition to the clinical and epidemiological profile, the severity of the disease was analyzed. Mixed lesions were found in 27.1%, valvar regurgitation in 72.9%, and complete regression of the valvar lesions was seen in 34.4% of the patients, mostly presenting mild dysfunctions. The recurrence rate per patient-year was 0.058 and out of a total of 85 recurrences, 21.4% occurred in the first and 7.5% in the second period. More severe degrees of carditis and significant valvar sequels presented a higher prevalence in patients with recurrences. The comparative analysis between the two periods showed no changes regarding the age at the primary attack, gender, type, and site of valvar lesions and affected joints; however, important modifications in the indices of severity were observed after the control of recurrences. A significant decrease in the prevalence of severe carditis, obstructive valvar sequels, hospital admissions, surgical approach, and deaths was seen. This investigation showed that although the clinical profile of presentation remains unchanged, the control of repeated attacks can improve the morbimortality rates. In this context, the secondary prophylaxis should be the first priority in the control of the disease in developing countries, taking into account the difficulties found for effective primordial and primary prevention.
引用
收藏
页数:5
相关论文
共 50 条
  • [1] Long-term antibiotic prophylaxis for prevention of rheumatic fever recurrence and progression to rheumatic heart disease
    Bray, Jonathan J. H.
    Thompson, Sophie
    Seitler, Samuel
    Ali, Syed Ahsan
    Yiu, Janice
    Salehi, Mahan
    Ahmad, Mahmood
    Pelone, Ferruccio
    Gashau, Hyeriju
    Shokraneh, Farhad
    Ahmed, Nida
    Cassandra, Miryan
    Marijon, Eloi
    Celermajer, David S.
    Providencia, Rui
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2024, (09):
  • [2] Rheumatic fever and long-term sequelae in children
    Saxena A.
    Current Treatment Options in Cardiovascular Medicine, 2002, 4 (4) : 309 - 319
  • [3] Long-term Outcomes for the Promoting CARE Suicide Prevention Program
    Hooven, Carole
    Herting, Jerald R.
    Snedker, Karen A.
    AMERICAN JOURNAL OF HEALTH BEHAVIOR, 2010, 34 (06): : 721 - 736
  • [4] TREATMENT AND LONG-TERM PROGNOSIS OF RHEUMATIC-FEVER
    KUSAKAWA, S
    ASAI, T
    KIGUCHI, H
    NAGAI, Y
    SONOBE, T
    JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION, 1975, 39 (02): : 175 - 176
  • [5] PREVENTION OF RECURRENT ATTACKS OF RHEUMATIC FEVER - PROBLEMS REVEALED BY LONG-TERM FOLLOW-UP
    LENDRUM, BL
    KOBRIN, C
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1956, 162 (01): : 13 - 16
  • [6] Long-term metformin adherence in the Diabetes Prevention Program Outcomes Study
    Walker, Elizabeth Arquin
    Gonzalez, Jeffrey S.
    Tripputi, Mark T.
    Dagogo-Jack, Samuel
    Matulik, Margaret J.
    Montez, Maria G.
    Tadros, Sameh
    Edelstein, Sharon L.
    BMJ OPEN DIABETES RESEARCH & CARE, 2020, 8 (01)
  • [7] Lack of antiphospolipid antibodies in long-term cardiac rheumatic fever
    de Carvalho, Jozelio Freire
    Goldenstein-Schainberg, Claudia
    RHEUMATOLOGY INTERNATIONAL, 2012, 32 (09) : 2951 - 2951
  • [8] Lack of antiphospolipid antibodies in long-term cardiac rheumatic fever
    Jozélio Freire de Carvalho
    Cláudia Goldenstein-Schainberg
    Rheumatology International, 2012, 32 : 2951 - 2951
  • [10] ESTABLISHING PRIORITIES IN A RHEUMATIC FEVER PREVENTION PROGRAM
    HERNANDE.CT
    BOLETIN DE LA OFICINA SANITARIA PANAMERICANA, 1970, 69 (04): : 281 - &